Study
ET Exome
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001000102 | Cancer Genomics |
Study Description
Agilent whole exome hybridisation capture will be performed on genomic DNA derived from 50 Essential Thrombocythemia Myeloproliferative Disease samples and matched normal DNA from the same patients. Samples will be multiplexed in one lane of Illumina HiSeq. Sequencing to a coverage of at least 30x will be performed and mapped to build 37 of the human reference genome to facilitate the identification of novel cancer genes.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001000129 |
Essential Thrombocythemia Myeloproliferative Disease exome sequencing
|
Illumina HiSeq 2000 | 189 |
Who archives the data?
